Deep Tech Startups

Grove Biopharma develops Bionic Biologics, a drug discovery platform combining AI-enabled molecular design, precision polymer chemistry, and experimental biology to target protein-protein interactions that are inaccessible to conventional therapeutics. The platform creates cell-penetrant, protein-scale molecules designed to engage intracellular targets for pharmaceutical applications.

5 investors

Haply builds haptic force-feedback controllers and a robotics workflow platform for robotics, simulation, medical training, research, and industrial automation. Its devices support teleoperation, 3D design input, skills training, and robot task capture and replay.

5 investors

HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease. The biotech company builds a regulatory genome platform to discover tissue- and cell-specific lncRNA targets and turn them into oligonucleotide-based therapies.

5 investors

Hearvana is developing acoustic intelligence technology aimed at enhancing listening capabilities for both humans and machines. The company is building audio processing products, currently accepting waitlist signups.

5 investors

Helicity Space develops fusion-based space propulsion and power technology intended to drive deep space transports for human and robotic exploration, national security, and commercial space missions. The company targets the space industry with fusion propulsion engines for interplanetary travel and resource applications.

5 investors

Hertha Metals develops a proprietary pyrometallurgical process to produce iron and steel more efficiently and cost-effectively. The company operates in the industrial materials and steelmaking sector, moving its technology from pilot to commercial-scale plants.

5 investors

Hexagon Bio develops novel payload mechanisms for antibody-drug conjugates (ADCs) aimed at overcoming resistance to current cancer treatments and expanding ADC indications. The company focuses on targeted cytotoxic therapy for cancer, drawing on human therapeutics derived from metagenomes.

5 investors

Hexium develops Atomic Vapor Laser Isotope Separation (AVLIS) technology that uses lasers and electric fields to enrich isotopes, starting with lithium. Its enriched isotopes are aimed at nuclear energy, nuclear medicine, and industrial applications.

5 investors

Hiverge builds an AI discovery engine that uses multiple parallel agents to automatically write and optimise algorithms for critical optimisation problems, from speeding up AI model training to solving combinatorial optimisation tasks. The company was founded by researchers from Google DeepMind and the University of Cambridge.

5 investors

HotHouse Therapeutics uses artificial intelligence and synthetic biology to reprogram plant biosynthetic pathways to create novel pharmaceutical compounds not achievable through traditional chemical synthesis.

5 investors

Hoxton Ventures is a venture capital firm that invests in AI and deeptech startups across the UK and Europe, providing capital, compute access, and infrastructure support to founders building transformative companies.

5 investors

Ideon Technologies uses cosmic-ray muon tomography to create subsurface density maps for mining companies, enabling mineral deposit identification and characterization while reducing environmental impact and operational risk.

5 investors

Illuminant Surgical develops an AI-powered real-time anatomical projection system called Skylight for spine surgery and interventional procedures, using computer vision and projection mapping to display medical imaging directly onto patients. The system is designed for surgical professionals across hospitals, ambulatory surgical centers, and specialty clinics to improve surgical guidance and workflow efficiency.

5 investors

ImmuneBridge is a company working in cell-based cancer immunotherapy, including research on engineered natural killer cells for solid tumor treatment.

5 investors

Immunophotonics is a clinical-stage biotech company developing novel treatments for solid-tumor cancers and infectious diseases by combining tumor ablation with systemic cancer immunotherapy. The company's intellectual property platform includes IP-001, designed to transform routine ablation procedures into systemically active cancer immunotherapy.

5 investors

Immuto Scientific uses patient-derived tissue models combined with computational structural proteomics and machine learning to identify disease-specific protein targets for drug discovery. The platform applies advanced mass spectrometry and molecular simulations to distinguish diseased from healthy tissues and accelerate therapeutic development.

5 investors

InchFab offers a modular, integrated semiconductor fabrication platform that combines hardware, processes, and tools into one system, letting users start small and scale up for prototyping and production. It targets micro-/nano-fabrication of specialized chips and MEMS devices, aiming to reduce turnaround time and cost.

5 investors

Indicio is a technology company focused on decentralized identity and verifiable credential solutions, offering products and services built on distributed ledger and network infrastructure. It serves organizations seeking trusted digital identity and data verification tools.

5 investors

IndoorAtlas develops an indoor positioning platform that enables mobile apps to determine location and navigate indoors using geomagnetic technology. The platform serves app developers and their end users who need location awareness in indoor environments.

5 investors

Marvell designs custom silicon and provides interconnect and network switch products for AI data-center infrastructure, serving hyperscalers, enterprise networks, and 5G carriers. Its portfolio spans custom compute, connectivity, security, and networking platforms for accelerated computing and telecommunications.

5 investors

Insamo develops an automated platform for drug discovery that designs, synthesizes, and tests cyclic peptides at scale using machine learning and proprietary experimental data. The company targets the development of treatments for challenging diseases through membrane-permeable and orally available compounds.

5 investors

Integral AI builds interactive world models, an agent generation platform for creating digital and real-world agents, and a multimodal input/output interface. The company develops AI infrastructure aimed at scalable general intelligence.

5 investors

IntegriCulture is a Japanese cellular agriculture company developing cell-culture systems and production technology for cultured foods, along with OEM/ODM cosmetics and supplements and sales of cell-culture consumables and equipment. It applies its "CulNet"/cell-culture technology to help address protein supply and offers products across the food and cosmetics sectors.

5 investors

Invact built Metaversity, an online learning platform offering backend, data analytics and full-stack programs structured into cohort-based learning pathways for students. The company served both B2C and B2B audiences through an LMS with onboarding, grading and progress-tracking systems.

5 investors